Thank you to everyone who has helped to raise over £30,000 to help find a cure for Duchenne!
Earlier this year, Furnley House held a party to celebrate its fifth birthday with its staff. Collectively, we all agreed that we wanted to do something to bring the Furnley House community together. We often get involved in local charitable events and help to raise awareness and funds for local causes. This year, we chose to work with Alex’s Wish after being inspired by Emma Hallam, Alex’s mum and her mission to cure Duchenne.
What is Duchenne Muscular Dystrophy?
Duchenne Muscular Dystrophy. is a serious muscle-wasting disease affecting 1 in every 3,500 new born boys. Those affected are wheelchair bound in early teens and completely paralysed by late teens. It is 100% fatal and children will not live beyond their twenties. Currently, there is no cure or effective treatments that will help all children at present. A medical breakthrough is certainly imminent but more funding is desperately needed.
Seven months into 2018, we’re really pleased to have smashed our fundraising target for Alex’s Wish to fund the research for this cure. Emma and Alex were so pleased with the amount raised at the Summer Ball that they created a short video to say thanks – click on the following link or copy and paste it into your browser: https://www.youtube.com/watch?v=k-dIwjPss5k
We want to thank everyone that came along to the Summer Ball and the Furnley House team who have been doing lots to raise funds for Alex’s wish. We’re really pleased to be working with Alex’s Wish and even more pleased to share how your generosity is making a difference and where your donations are being spent
Update on Gene Therapy
In recent years, the community has watched with hope as pre-clinical data has emerged showing the promise of gene therapy as a valuable treatment for everyone living with Duchenne Muscular Dystrophy. 2018 began with much hope: Three companies – Solid Biosciences, Sarepta and Pfizer, began dosing patients in separate clinical trials using this approach. And there’s been more exciting developments in the last few weeks.
Solid Biosciences announced that the U.S Food and Drug Administration (FDA), had lifted the clinical hold on IGNITE DMD, the company’s Phase I/II clinical trial for its investigational microdystrophin gene transfer for the treatment of DMD. Solid Biosciences has dosed one patient so far and they are now free to continue to dose patients. – Alex’s Wish invested in this.
Sarepta Therapeutics announced positive preliminary results from 3 of its patients dosed in its Phase 1/2a gene therapy clinical trial, conducted by Jerry Mendell M.D of Nationwide Children’s Hospital. All three children showed that they were producing micro-dystrophin in their muscle fibers. Consequently, they saw a significant drop in an enzyme known as creatine kinase (CK) which is indicative of muscle damage. No serious side effects were seen.
Support the team
With your help and donations, we’ve already raised over £30,000 but we’re not going to stop there -we’ve got lots more planned for the year to raise for funds to cure Duchenne! And you can continue to help by supporting two very brave colleagues who have ‘volunteered’ to do a tandem skydive on 11 August 2018….
Gordon is petrified of heights and John was convinced it was a good idea by the team…They’ve already raised a fantastic amount but every pound makes a huge difference! And you can donate as little as £2 or as much as you like on the links below:
And there’s more…
Later on this year, several staff members of Furnley House are attempting the Wolf Run in September. Watch this space to find out who, where and when…